Stemcentrx

Biotech & Life Sciences · South San Francisco, United States · Founded 2008

Develops innovative therapies for cancer

Valuation $10–50B

Headcount <100

Unlock exact values

Power Law Decacorn$10B+ valuation tier

Talent graph

Stemcentrx's talent

Book a demo to see the people

Founders /100 quality score

Key operators quality score

Potential founders likely future founders

Startup mafia 4 alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Investors

7 investors on Stemcentrx's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series B+ 7 investors entered at this stage

Capital Group

Artis Ventures

James Hong

Stemcentrx mafia

Startups founded by Stemcentrx alumni

Former Stemcentrx employees who went on to start their own companies. Sorted by Dealroom signal score.

Enliven TherapeuticsEst. 2019

Sam KintzUnited States

Signal score89

InterVennEst. 2017

Lieza MarieUnited States

Signal score70

ProfoundBioEst. 2018

THTae HanUnited States

Signal score69

ZitaraEst. 2019

Evan MurphyUnited States

Signal score61

Book a demo to explore the full alumni network →

Global footprint

Where Stemcentrx has talent and traffic

Workforce by country

1 countries with
team presence

🇺🇸 United States100%

1 country shown

Patent intelligence

$25M patent portfolio · 19 active families

Estimated portfolio value

$25M

0.25% of valuation · 12.7× smaller than top peer MorphoSys ($321M)

19 active patent families

Where Stemcentrx innovates Anti antibodyAntibody-drug conjugateAntiendomysial antibodiesBiochemistryCancer research

Where Stemcentrx concentrates vs peers

Each axis is a top-10 topic across Stemcentrx and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Stemcentrx

An AI-synthesized read of the highest-engagement posts about Stemcentrx on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Stemcentrx on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles